CD4 and type 1 diabetes mellitus: In this model, as well as in T1D in humans, it is suggested that CD4+ T cells specific for β-cell autoantigens have pro-inflammatory phenotype characterized by the secretion of IFN-γ and/or IL-17 (1, 19–21).